Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

AIM: To evaluate whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, could reduce the severity of gastric precancerous lesions following Helicobacter pylori (H pylori) eradication. METHODS: H pylori-eradicated patients with gastric precancerous lesions randomly received either celecox...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zhang, Li-Jing, Wang, Shi-Yan, Huo, Xiao-Hui, Zhu, Zhen-Long, Chu, Jian-Kun, Ma, Jin-Cheng, Cui, Dong-Sheng, Gu, Ping, Zhao, Zeng-Ren, Wang, Ming-Wei, Yu, Jun
Formato: Artigo
Idioma:Inglês
Publicado: The WJG Press and Baishideng 2009
Assuntos:
Orignal Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2695888/
https://ncbi.nlm.nih.gov/pubmed/19522023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.2731
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares